Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 Jun 22:2025.06.19.660507.
doi: 10.1101/2025.06.19.660507.

Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1

Affiliations

Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1

Alyssa Ward et al. bioRxiv. .

Abstract

ROR1 is a member of the receptor tyrosine kinase (RTK) family that plays a crucial role during organogenesis of bone and neural systems by regulating non-canonical Wnt signaling. Misregulation of ROR1 is additionally a causative factor for carcinogenesis in solid and liquid tumors. However, we have a poor understanding of how ROR1 activity is regulated. We employed a recently developed single-molecule method termed SiMPull-POP to study the oligomeric state of ROR1. RTK function is typically triggered by ligand binding, which promotes self-assembly of RTKs to form dimers and in some cases oligomers. However, our data indicate that ROR1 does not follow this paradigm. Instead, ROR1 forms dimers and oligomers in a process that is not affected by the presence of the ROR1 ligand Wnt5a. Additional experiments indicate that the transmembrane domain of ROR1 has a strong tendency to self-assemble, suggesting that this domain modulates ROR1 dimerization. Investigation into a regulatory mechanism for ROR1 self-assembly led to evaluation of the role of the lipid cholesterol, which plays pleiotropic roles in Wnt signaling. Cholesterol was found to promote the assembly of ROR1, and our results point to the transmembrane domain as the region where cholesterol exerts the regulatory effect. Taken together, our results indicate that ROR1 self-assembles in human cells; however, unlike other RTKs, this process is not stabilized by ligand binding but is instead facilitated by membrane cholesterol.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. ROR1 forms dimers and oligomers.
Oligomeric distribution of ROR1 isolated in DIBMALPs prepared from HEK293T cells, as determined by SiMPull-POP. N=3. Data are mean ± S.D.
Figure 2.
Figure 2.. Dimerization of ROR1 TMD in HEK293T cells.
(A) Schematic representation of the Bimolecular Fluorescent Complementation (BiFC) assay. (B) Amino acid sequences fused to VFP halves used in the assay and their predicted ΔGGapp) values for membrane insertion in kcal/mol. (C) Relative fluorescence units (RFU) of each tested homo-oligomer in the BiFC assay. Mean and standard deviation for at least 13 independent experiments are shown. The individual value of each experiment is represented by a dot. The VN-GpA/VC-GpA homodimer is used as a positive control and to normalize values across experiments. The Lep H2 TMD was included as negative control. The homo-oligomers that produced fluorescence levels significantly higher than the H2 TMD homo-oligomer (two-tailed homoscedastic t-test) are highlighted in green. The lower panels display western blot data for the VN and VC constructs expression levels detected by α-c-Myc antibody and α-HA antibody respectively. An α-GPADH antibody was used as a loading control. RFU values were normalized to expression levels.
Figure 3:
Figure 3:. Cholesterol removal promotes monomeric ROR1.
(A) Cholesterol levels in control conditions and after treatment with MβCD. (B) Oligomeric distribution of ROR1. All experiments were performed in HEK293T cells. A two-way ANOVA followed by a multiple comparison unpaired t-tests was run for statistical analysis. N=3. Data are mean ± S.D. (C) BiFC of ROR1 TMD homo-oligomers in control conditions and after MβCD treatment. Mean and standard deviation are shown. A two-tailed homoscedastic t-test was used for statistical analysis.
Figure 4:
Figure 4:. ROR1-GFP partitions into GPMV Lo domains more efficiently than the RTK EphA2-GFP.
(A) Representative images of GPMVs from control and MβCD treated HeLa cells transfected with ROR1-GFP (scale bars = 5 μm) (left). Ld partition coefficient (Kp) of ROR1-GFP in phase-separated GPMVs (right). (B) Representative GPMVs derived from HeLa cells transfected with EphA2-GFP in control and MβCD treated conditions (scale bars = 5 μm) (left). Kp of EphA2-GFP in phase separated GPMVs (right). The Kp was determined by Equation 1. Total number of GPMVs analyzed per condition were 19 (ROR1, Control), 15 (ROR1, MβCD), 28 (EphA2, Control), and 23 (EphA2, MβCD). Data are mean ± S.D., with Kp values for at least 3 biological replicates.

Similar articles

References

    1. Borcherding N., Kusner D., Liu G. H., and Zhang W. (2014) ROR1, an embryonic protein with an emerging role in cancer biology. Protein Cell 5, 496–502 - PMC - PubMed
    1. Mikels A. J., and Nusse R. (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4, e115. - PMC - PubMed
    1. Fukuda T., Chen L., Endo T., Tang L., Lu D., Castro J. E., Widhopf G. F., Rassenti L. Z., Cantwell M. J., Prussak C. E., Carson D. A., and Kipps T. J. (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proceedings of the National Academy of Sciences 105, 3047–3052 - PMC - PubMed
    1. Billiard J., Way D. S., Seestaller-Wehr L. M., Moran R. A., Mangine A., and Bodine P. V. N. (2005) The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells. Molecular Endocrinology 19, 90–101 - PubMed
    1. Liu J., Xiao Q., Xiao J., Niu C., Li Y., Zhang X., Zhou Z., Shu G., and Yin G. (2022) Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy 7, 3. - PMC - PubMed

Publication types

LinkOut - more resources